AlphaCore Capital’s Tenet Healthcare THC Stock Holding History

AlphaCore Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$244K	Buy	+955	New	+$235K	﹤0.01%	1214

Other funds holding THC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

AlphaCore Capital's THC Position: Q3 2026 in Review

AlphaCore Capital opened a new position in Tenet Healthcare (THC) in Q3 2026: 955 shares worth $244K. The stake represents ﹤0.01% of the portfolio and ranks #1214 among its holdings.

366 funds tracked by Wall St. Rank hold THC as of Q3 2026.

AlphaCore Capital held 955 shares of Tenet Healthcare worth $244K as of Q3 2026.
Tenet Healthcare was a new AlphaCore Capital position in Q3 2026.
Tenet Healthcare made up ﹤0.01% of AlphaCore Capital's portfolio in Q3 2026, its #1214 holding.
366 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on AlphaCore Capital's 13F filing for Q3 2026, filed 4 Nov 2026.